Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomised, Placebo-Controlled Study Evaluating the Effects of a Novel Multi-Targeted Dermatologist-Formulated Oral Supplement on Skin, Hair, Sleep, Energy, Cognition, Libido, and Longevity

NCT07827651 is registered in ClinicalTrials.gov with IDI Skincare Limited as lead sponsor.

NCT NCT07827651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07827651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomised, Placebo-Controlled Study Evaluating the Effects of a Novel Multi-Targeted Dermatologist-Formulated Oral Supplement on Skin, Hair, Sleep, Energy, Cognition, Libido, and Longevity
Lead sponsor
IDI Skincare Limited
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 8, 2025
Completion date
November 30, 2026
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biological ageing, biological aging marker, biological clocks, cognitive processing speed, effect of oral nutritional supplementation on skin, hair, sleep, energy, cognition and sexual wellbeing in healthy adults, hair aging, healthspan improvement, healthy ageing, longevity, recovery, skin ageing, sleep